Shaw, Executive Chairperson of Biocon & Biocon Biologics, said the pharma industry faces long 'lab-to-market' timelines, high ...

Prime Minister Narendra Modi on Friday asked scientists and entrepreneurs to focus more on research and development (R&D), ...

Vana Charitable Trust partners with Syngene Biocon Foundation to restore mangroves along Netravathi riverbank in Mangaluru.

Biocon Limited ( ($IN:BIOCON) ) has provided an update. Biocon Limited has released the transcript of its Q1 FY26 earnings call, which was held on ...

The company is also focused on strategic capital deployment. It has already invested in GLP-1 drug substance and drug product ...

Trading at Rs 367.85, Biocon shows a positive move in today's early trading session, with the stock included in the Nifty Midcap 150 index.

Motilal Oswal is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 410 in its research ...

The biopharma company's stock fell as much as 3.60 per cent during the day to ₹331 per share, the lowest level since June 6 ...

Dhananjay Sinha of Systematix Group notes US tariffs impact on pharma. A correction is seen in US-exposed companies. Tariff ...

Starting from Monday, Bengaluru's yellow line will be operation across 16 stations connecting key areas of the city.

Biocon reported a 95% drop in net profit for the June quarter, with earnings falling from Rs 660 crore last year to Rs 31 crore. Despite this, operating revenue and EBITDA showed growth, and the ...

Biocon Biologics receives USFDA approval for Kirsty, an interchangeable biosimilar to NovoLog, expanding their insulin portfolio.